News for Pfizer Inc. (PFE.SN)

At a Cabinet meeting earlier this month, Trump said he planned to impose a 50% tariff on copper in the coming weeks, and that he expected pharmaceutical tariffs to grow as high as 200% after giving companies a year to bring manufacturing back to the US. Trump has already announced investigations under Section 232 of the Trade Expansion Act of 1962 on drugs, arguing a flood of foreign imports was threatening national security.

President Trump plans to impose tariffs on pharmaceuticals and semiconductors, impacting companies like Eli Lilly and Apple.

Trump plans steep tariffs on pharmaceuticals and semiconductors by July-end, eyes India trade deal as part of broader “reciprocal” tariff rollout by Aug 1.

Pfizer Inc. (NYSE:PFE) is one of the Best Large Cap Value Stocks to Invest In. Morningstar reduced its moat rating for the company to narrow due to the portfolio setbacks as well as policy risk. That being said, the firm also added that Pfizer Inc. (NYSE:PFE)’s foundation is strong on the basis of steady cash flows coming […]

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company's transformation and growth in a

Key Takeaways: Pfizer and BioNTech are contesting a UK court ruling favoring Moderna's vaccine patent. Analysts predict a potential 12.15% upside for Pfi

Pfizer (PFE) has reported promising top-line findings from the Phase 3 EMBARK study, which examined the effectiveness of xtandi, also known as enzalutamide, bot

XTANDI® plus leuprolide significantly improves overall survival in non-metastatic hormone-sensitive prostate cancer. The Phase 3 EMBARK study shows a m

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the ov

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company’s bottom-line figure.

President Donald Trump vowed to push forward with his aggressive tariff regime in the coming days, stressing he would not offer additional extensions on

How do Aussies invest on the New York Stock Exchange (NYSE) and buy shares of companies like Microsoft (NASDAQ: MSFT) and Visa (NYSE: V)?

Regulatory momentum builds for bexobrutideg with multiple designations across the United States and EU, Including EMA PRIME and FDA Fast Track for CLL/SLL SAN

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my updated look at PFE stock prospects.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

More than $100 billion worth of London-listed companies have announced or executed plans to move to New York in recent years.